FOXO Technologies Implements 1-for-1.99 Reverse Stock Split-March 2024-www.financetom.com

FOXO Technologies Implements 1-for-1.99 Reverse Stock Split

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FOXO Technologies Implements 1-for-1.99 Reverse Stock Split

Jul 28, 2025 9:22 AM

11:47 AM EDT, 07/28/2025 (MT Newswires) -- FOXO Technologies ( FOXO ) said in a Monday filing that it has implemented a 1-for-1.99 reverse stock split, effective Sunday.

The company said its shares started trading on a post-split basis on Monday.

Price: 0.24, Change: -0.01, Percent Change: -5.24

Previous page： Pacific Premier Bancorp's Q4 Adjusted Earnings Decrease Next page： GE Aerospace forecasts 2025 profit above estimates on robust aftermarket demand

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pacific Premier Bancorp's Q4 Adjusted Earnings Decrease

Jan 23, 2025

06:20 AM EST, 01/23/2025 (MT Newswires) -- Pacific Premier Bancorp ( PPBI ) reported Q4 adjusted earnings Thursday of $0.35 per diluted share, down from $0.51 a year earlier. Analysts surveyed by FactSet expected $0.31. Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and noninterest income, was $144.5 million. Analysts surveyed by FactSet...

GE Aerospace forecasts 2025 profit above estimates on robust aftermarket demand

Jan 23, 2025

Jan 23 (Reuters) - GE Aerospace on Thursday forecast profit for the current year above estimates, as persistent shortage of new aircraft forces airlines to fly older jets, creating strong demand for its high-margin parts and services. The company also announced plans to increase its share buybacks to $7 billion in 2025 and dividend by 30%. Production challenges at Boeing...

Johnson & Johnson Says Nipocalimab Meets Primary Endpoint in Phase 3 Myasthenia Gravis Study

Jan 23, 2025

06:17 AM EST, 01/23/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday its phase 3 study of experimental therapy, nipocalimab, in adults with generalized myasthenia gravis met its primary endpoint. The company said the study showed a statistically significant and clinically meaningful improvement in the MG-ADLa score, which measures the impact of myasthenia gravis on daily activities,...

Westgold Resources Hits Record With Q2 Gold Production

Jan 23, 2025

06:23 AM EST, 01/23/2025 (MT Newswires) -- Westgold Resources ( WGXRF ) late on Wednesday said it achieved its highest quarterly gold production in the second quarter of fiscal year 2025 at 80,866 ounces and generated A$45 million in net mine cashflow. Total output for the quarter included 46,461 ounces from the Murchison and 34,425 ounces from the Southern Goldfields....